[1] K. Komatović, A. Matošević, N. Terzić-Jovanović, S. Žunec, S. Šegan, M. Zlatović, N. Maraković, A. Bosak, D. M. Opsenica, 4-Aminoquinoline-Based Adamantanes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer’s Disease. Pharmaceutics, 2022, 14, 1305.
[2] К. Komatović, А. Matošević, М. Zlatović, D. Sladić, A. Bosak, D. M. Opsenica, Hybrids of 4- aminoquinolines and adamantane as inhibitors of AChE, J. Serb. Chem. Soc., 2025.